Theremia

Theremia is a Paris-based biotechnology company leveraging artificial intelligence to revolutionize drug discovery through precision pharmacology. The company's platform integrates high-throughput biological data with advanced machine learning algorithms to identify new therapeutic applications for existing compounds and optimize drug combinations. By focusing on drug repurposing and the identification of novel targets, Theremia aims to significantly reduce the time and cost associated with traditional drug development. Their approach is particularly geared towards addressing unmet medical needs in complex diseases and rare conditions. The company utilizes a data-driven strategy to predict clinical outcomes and patient responses more accurately than conventional methods. Theremia's technology enables the exploration of vast chemical and biological spaces to uncover hidden synergies between drugs.